Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
ACTB
Actin, cytoplasmic 1 |
3 |
6 |
High-throughput |
0.861 | High |
|
|
ACTC
Actin, alpha cardiac muscle 1 |
2 |
5 |
High-throughput |
0.811 | High |
|
|
ACTBL
Beta-actin-like protein 2 |
2 |
6 |
High-throughput |
0.811 | High |
|
|
PACN2
Protein kinase C and casein kinase substrate in neurons protein 2 |
6 |
6 |
High-throughput |
0.736 | High |
|
|
ACTBM
Putative beta-actin-like protein 3 |
2 |
6 |
High-throughput |
0.712 | High |
|
|
PACN1
Protein kinase C and casein kinase substrate in neurons protein 1 |
4 |
6 |
High-throughput |
0.700 | High |
|
|
PACN3
Protein kinase C and casein kinase substrate in neurons protein 3 |
4 |
6 |
High-throughput |
0.699 | High |
|
|
ARP2
Actin-related protein 2 |
1 |
6 |
High-throughput |
0.691 | High |
|
|
ACTG
Actin, cytoplasmic 2 |
1 |
6 |
High-throughput |
0.691 | High |
|
|
WDR47
WD repeat-containing protein 47 |
2 |
1 |
High-throughput |
0.628 | High |
|
|
FHL3
Four and a half LIM domains protein 3 |
3 |
1 |
High-throughput |
0.609 | High |
|
|
FBW1B
F-box/WD repeat-containing protein 11 |
2 |
0 |
High-throughput |
0.602 | High |
|
|
EZRI
Ezrin |
2 |
3 |
High-throughput |
0.584 | High |
|
|
MYO1C
Unconventional myosin-Ic |
1 |
1 |
High-throughput |
0.536 | High |
|
|
DREB
Drebrin |
1 |
1 |
High-throughput |
0.536 | High |
|
|
MY18A
Unconventional myosin-XVIIIa |
1 |
1 |
High-throughput |
0.536 | High |
|
|
MYO19
Unconventional myosin-XIX |
1 |
1 |
High-throughput |
0.536 | High |
|
|
PDLI7
PDZ and LIM domain protein 7 |
1 |
2 |
High-throughput |
0.536 | High |
|
|
NLGN3
Neuroligin-3 |
1 |
0 |
High-throughput |
0.518 | High |
|
|
FLNA
Filamin-A |
1 |
0 |
High-throughput |
0.513 | High |
|
|
MYH9
Myosin-9 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
IQGA1
Ras GTPase-activating-like protein IQGAP1 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
CAZA2
F-actin-capping protein subunit alpha-2 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
SYNPO
Synaptopodin |
1 |
0 |
High-throughput |
0.513 | High |
|
|
VMP1
Vacuole membrane protein 1 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
ANLN
Anillin |
1 |
0 |
High-throughput |
0.513 | High |
|
|
LIMA1
LIM domain and actin-binding protein 1 |
1 |
0 |
High-throughput |
0.513 | High |
|
|
AKT3
RAC-gamma serine/threonine-protein kinase |
1 |
0 |
High-throughput |
0.513 | High |
|
|
MARE1
Microtubule-associated protein RP/EB family member 1 |
1 |
1 |
High-throughput |
0.489 | High |
|
|
PRC1
Protein regulator of cytokinesis 1 |
1 |
1 |
High-throughput |
0.479 | High |
|
|
RADI
Radixin |
1 |
3 |
High-throughput |
0.479 | High |
|
|
GSK3A
Glycogen synthase kinase-3 alpha |
1 |
1 |
High-throughput |
0.479 | High |
|
|
GSK3B
Glycogen synthase kinase-3 beta |
1 |
1 |
High-throughput |
0.479 | High |
|
|
CDC42
Cell division control protein 42 homolog |
1 |
4 |
High-throughput |
0.479 | High |
|
|
1433G
14-3-3 protein gamma |
1 |
9 |
High-throughput |
0.479 | High |
|
|
RHOB
Rho-related GTP-binding protein RhoB |
1 |
3 |
High-throughput |
0.479 | High |
|
|
RAC1
Ras-related C3 botulinum toxin substrate 1 |
1 |
3 |
High-throughput |
0.479 | High |
|
|
CAV1
Caveolin-1 |
1 |
1 |
High-throughput |
0.479 | High |
|
|
1433F
14-3-3 protein eta |
1 |
9 |
High-throughput |
0.479 | High |
|
|
ZYX
Zyxin |
1 |
1 |
High-throughput |
0.479 | High |
|
|
RHOU
Rho-related GTP-binding protein RhoU |
1 |
4 |
High-throughput |
0.479 | High |
|
|
RHOJ
Rho-related GTP-binding protein RhoJ |
1 |
4 |
High-throughput |
0.479 | High |
|
|
RHOF
Rho-related GTP-binding protein RhoF |
1 |
4 |
High-throughput |
0.479 | High |
|
|
MARE3
Microtubule-associated protein RP/EB family member 3 |
1 |
1 |
High-throughput |
0.479 | High |
|
|
RASK
GTPase KRas |
1 |
0 |
High-throughput |
0.458 | High |
|
|
GCSP
Glycine dehydrogenase |
1 |
0 |
High-throughput |
0.458 | High |
|
|
KIF14
Kinesin-like protein KIF14 |
1 |
0 |
High-throughput |
0.458 | High |
|
|
ATG9A
Autophagy-related protein 9A |
1 |
0 |
High-throughput |
0.458 | High |
|
|
CHM4B
Charged multivesicular body protein 4b |
1 |
0 |
High-throughput |
0.458 | High |
|
|
ECT2
Protein ECT2 |
1 |
0 |
High-throughput |
0.458 | High |
|
|
1433S
14-3-3 protein sigma |
1 |
9 |
High-throughput |
0.437 | High |
|
|
HOOK3
Protein Hook homolog 3 |
1 |
2 |
High-throughput |
0.437 | High |
|
|
NINL
Ninein-like protein |
1 |
1 |
High-throughput |
0.437 | High |
|
|
ZDHC5
Palmitoyltransferase ZDHHC5 |
1 |
0 |
High-throughput |
0.426 | High |
|
|
PKHA7
Pleckstrin homology domain-containing family A member 7 |
1 |
1 |
High-throughput |
0.407 | High |
|
|
TMOD3
Tropomodulin-3 |
2 |
0 |
High-throughput |
0.328 | High |
|
|
HEM1
5-aminolevulinate synthase, non-specific, mitochondrial |
2 |
0 |
High-throughput |
0.316 | High |
|
|
RHG39
Rho GTPase-activating protein 39 |
2 |
0 |
High-throughput |
0.298 | High |
|
|
PP1B
Serine/threonine-protein phosphatase PP1-beta catalytic subunit |
1 |
0 |
High-throughput |
0.279 | Low |
|
|
HTRA4
Serine protease HTRA4 |
1 |
0 |
High-throughput |
0.279 | Low |
|
|
EP300
Histone acetyltransferase p300 |
1 |
0 |
High-throughput |
0.279 | Low |
|
|
SAHH3
Adenosylhomocysteinase 3 |
1 |
0 |
High-throughput |
0.279 | Low |
|
|
MEN1
Menin |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
INS
Insulin [Cleaved into: Insulin B chain; Insulin A chain] |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
RFA2
Replication protein A 32 kDa subunit |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
RFA1
Replication protein A 70 kDa DNA-binding subunit |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
RFA3
Replication protein A 14 kDa subunit |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
FBX22
F-box only protein 22 |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
DOT1L
Histone-lysine N-methyltransferase, H3 lysine-79 specific |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
ESR2
Estrogen receptor beta |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
TRRAP
Transformation/transcription domain-associated protein |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
